Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN 3 transcatheter heart valve system

ConclusionsPPVI with the S3 valve appears feasible and safe in a wide range of patients with congenital heart defects, with good short-term haemodynamic and functional outcomes. Longer-term outcomes remain to be described. Clinicaltrials.gov identifier NCT02777892.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research